348 related articles for article (PubMed ID: 34114204)
1. COVID-19 and immunothrombosis: emerging understanding and clinical management.
Shaw RJ; Bradbury C; Abrams ST; Wang G; Toh CH
Br J Haematol; 2021 Aug; 194(3):518-529. PubMed ID: 34114204
[TBL] [Abstract][Full Text] [Related]
2. Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia.
Nicolai L; Leunig A; Brambs S; Kaiser R; Joppich M; Hoffknecht ML; Gold C; Engel A; Polewka V; Muenchhoff M; Hellmuth JC; Ruhle A; Ledderose S; Weinberger T; Schulz H; Scherer C; Rudelius M; Zoller M; Keppler OT; Zwißler B; von Bergwelt-Baildon M; Kääb S; Zimmer R; Bülow RD; von Stillfried S; Boor P; Massberg S; Pekayvaz K; Stark K
J Thromb Haemost; 2021 Feb; 19(2):574-581. PubMed ID: 33217134
[TBL] [Abstract][Full Text] [Related]
3. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation.
Sung PS; Yang SP; Peng YC; Sun CP; Tao MH; Hsieh SL
J Biomed Sci; 2022 Jul; 29(1):52. PubMed ID: 35820906
[TBL] [Abstract][Full Text] [Related]
4. Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies.
Gando S; Wada T
Front Immunol; 2021; 12():649122. PubMed ID: 34177896
[TBL] [Abstract][Full Text] [Related]
5. Patients with COVID-19: in the dark-NETs of neutrophils.
Ackermann M; Anders HJ; Bilyy R; Bowlin GL; Daniel C; De Lorenzo R; Egeblad M; Henneck T; Hidalgo A; Hoffmann M; Hohberger B; Kanthi Y; Kaplan MJ; Knight JS; Knopf J; Kolaczkowska E; Kubes P; Leppkes M; Mahajan A; Manfredi AA; Maueröder C; Maugeri N; Mitroulis I; Muñoz LE; Narasaraju T; Naschberger E; Neeli I; Ng LG; Radic MZ; Ritis K; Rovere-Querini P; Schapher M; Schauer C; Simon HU; Singh J; Skendros P; Stark K; Stürzl M; van der Vlag J; Vandenabeele P; Vitkov L; von Köckritz-Blickwede M; Yanginlar C; Yousefi S; Zarbock A; Schett G; Herrmann M
Cell Death Differ; 2021 Nov; 28(11):3125-3139. PubMed ID: 34031543
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications.
Lim MS; Mcrae S
Crit Rev Oncol Hematol; 2021 Dec; 168():103529. PubMed ID: 34800652
[TBL] [Abstract][Full Text] [Related]
7. A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy.
Goswami J; MacArthur TA; Sridharan M; Pruthi RK; McBane RD; Witzig TE; Park MS
Shock; 2021 Jun; 55(6):700-716. PubMed ID: 33378321
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of immunothrombosis in COVID-19.
Portier I; Campbell RA; Denorme F
Curr Opin Hematol; 2021 Nov; 28(6):445-453. PubMed ID: 34232139
[TBL] [Abstract][Full Text] [Related]
9. The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19.
Iliadi V; Konstantinidou I; Aftzoglou K; Iliadis S; Konstantinidis TG; Tsigalou C
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065210
[TBL] [Abstract][Full Text] [Related]
10. Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps.
Bautista-Becerril B; Campi-Caballero R; Sevilla-Fuentes S; Hernández-Regino LM; Hanono A; Flores-Bustamante A; González-Flores J; García-Ávila CA; Aquino-Gálvez A; Castillejos-López M; Juárez-Cisneros A; Camarena A
Biomolecules; 2021 May; 11(5):. PubMed ID: 34066385
[TBL] [Abstract][Full Text] [Related]
11. How to recognize and manage COVID-19-associated coagulopathy.
Gerber GF; Chaturvedi S
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):614-620. PubMed ID: 34889412
[TBL] [Abstract][Full Text] [Related]
12. COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response.
Jayarangaiah A; Kariyanna PT; Chen X; Jayarangaiah A; Kumar A
Clin Appl Thromb Hemost; 2020; 26():1076029620943293. PubMed ID: 32735131
[TBL] [Abstract][Full Text] [Related]
13. Interplay between inflammation and thrombosis in cardiovascular pathology.
Stark K; Massberg S
Nat Rev Cardiol; 2021 Sep; 18(9):666-682. PubMed ID: 33958774
[TBL] [Abstract][Full Text] [Related]
14. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms.
Loo J; Spittle DA; Newnham M
Thorax; 2021 Apr; 76(4):412-420. PubMed ID: 33408195
[TBL] [Abstract][Full Text] [Related]
15. Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers.
Ebrahimi R; Nasri F; Kalantari T
Ann Hematol; 2024 Jun; 103(6):1819-1831. PubMed ID: 38349409
[TBL] [Abstract][Full Text] [Related]
16. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis.
Gando S; Wada T
Shock; 2022 Jan; 57(1):1-6. PubMed ID: 34172612
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Immunothrombosis by SARS-CoV-2.
Hernández-Huerta MT; Pérez-Santiago AD; Pérez-Campos Mayoral L; Sánchez Navarro LM; Rodal Canales FJ; Majluf-Cruz A; Matias-Cervantes CA; Pérez-Campos Mayoral E; Romero Díaz C; Mayoral-Andrade G; Martínez Cruz M; Luna Ángel J; Pérez-Campos E
Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827548
[TBL] [Abstract][Full Text] [Related]
18. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond.
Zhu Y; Chen X; Liu X
Front Immunol; 2022; 13():838011. PubMed ID: 35309344
[TBL] [Abstract][Full Text] [Related]
19. Preventing the development of severe COVID-19 by modifying immunothrombosis.
Morris G; Bortolasci CC; Puri BK; Olive L; Marx W; O'Neil A; Athan E; Carvalho A; Maes M; Walder K; Berk M
Life Sci; 2021 Jan; 264():118617. PubMed ID: 33096114
[TBL] [Abstract][Full Text] [Related]
20. Platelets: "multiple choice" effectors in the immune response and their implication in COVID-19 thromboinflammatory process.
Rolla R; Puricelli C; Bertoni A; Boggio E; Gigliotti CL; Chiocchetti A; Cappellano G; Dianzani U
Int J Lab Hematol; 2021 Oct; 43(5):895-906. PubMed ID: 33749995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
